Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Orthotopic liver transplantation for fulminant hepatitis B.

Literature DB >> 11819607

Orthotopic liver transplantation for fulminant hepatitis B.

Xiao-Shun He, Jie-Fu Huang, Gui-Hua Chen, Qian Fu, Xiao-Feng Zhu, Min-Qiang Lu, Guo-Dong Wang, Xiang-Dong Guan.

Abstract

Entities: Disease

Year: 2000 PMID： 11819607 PMCID： PMC4688761 DOI： 10.3748/wjg.v6.i3.398

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

× No keyword cloud information.

8 in total

1. Liver transplantation for patients with hepatitis B: what have we learned from our results?

Authors: J R Lake; T L Wright
Journal: Hepatology Date: 1991-04 Impact factor: 17.425

2. Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection.

Authors: Z Ben-Ari; D Shmueli; E Mor; E Shaharabani; N Bar-Nathan; Z Shapira; R Tur-Kaspa
Journal: Transplant Proc Date: 1997-09 Impact factor: 1.066

3. Hepatic failure in infants on total parenteral nutrition (TPN): clinical and histopathologic observations.

Authors: J E Hodes; J L Grosfeld; T R Weber; R L Schreiner; J F Fitzgerald; L D Mirkin
Journal: J Pediatr Surg Date: 1982-10 Impact factor: 2.545

4. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients.

Authors: H I Wright; J S Gavaler; D H Van Theil
Journal: Transplantation Date: 1992-01 Impact factor: 4.939

5. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications.

Authors: J G O'Grady; H M Smith; S E Davies; H M Daniels; P T Donaldson; K C Tan; B Portmann; G J Alexander; R Williams
Journal: J Hepatol Date: 1992-01 Impact factor: 25.083

6. Early indicators of prognosis in fulminant hepatic failure.

Authors: J G O'Grady; G J Alexander; K M Hayllar; R Williams
Journal: Gastroenterology Date: 1989-08 Impact factor: 22.682

7. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.

Authors: F Bonino; F Rosina; M Rizzetto; R Rizzi; E Chiaberge; R Tardanico; F Callea; G Verme
Journal: Gastroenterology Date: 1986-05 Impact factor: 22.682

8. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation.

Authors: J R Nery; D Weppler; M Rodriguez; P Ruiz; E R Schiff; A G Tzakis
Journal: Transplantation Date: 1998-06-27 Impact factor: 4.939

8 in total

4 in total

Orthotopic liver transplantation for fulminant hepatitis B.

1. Liver transplantation for patients with hepatitis B: what have we learned from our results?

2. Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection.

3. Hepatic failure in infants on total parenteral nutrition (TPN): clinical and histopathologic observations.

4. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients.

5. Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications.

6. Early indicators of prognosis in fulminant hepatic failure.

7. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe.

8. Efficacy of lamivudine in controlling hepatitis B virus recurrence after liver transplantation.

1. Prevention of grafted liver from reperfusive injury.

2. Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine.

3. Influence of intrauterine injection of rat fetal hepatocytes on rejection of rat liver transplantation.

4. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.